Analytics: Manufacturing Scale Label Free Single Cell Analysis
Webinar Date/Time: Thursday June 29, 2023 at 2pm EDT | 1pm CDT | 11am PDT
In this webcast, learn the importance of analytical characterization of material. Discover how it helps maintain quality attributes within specified limits, identifies potential CMC problems, and addresses them in early manufacturing development.
Register Free: https://www.pharmtech.com/pt_w/label-free
Event Overview:
In this webinar learn about a label-free single cell analysis capability where the use of antibodies or genetic labeling is not required. This new type of laser physics approach offers benefits for analysis compared with conventional label-based flow cytometry methods.
Key Learning Objectives
- Detect and quantitate viral vector production of proteins and antibodies during R&D and manufacturing.
- Measure viral infectivity for vaccine R&D, process development and optimization, formulations, and potency.
- Characterize AAV, lentivirus and retrovirus transduction and transfection monitoring. iPSC differentiation monitoring.
- Measure changes in optical forces and cytoskeletal changes (deformability) for differentiated and dedifferentiated cells in Induced Pluripotent Stem Cells
Who Should Attend
- Advanced therapy medicinal products scientists
- Cell and gene therapy manufacturers
- Regulatory and government relations personnel
- Viral vector manufacturers
- Oncologists and immunologists
- Potency assay researchers
- CAR-T and blood disorder physicians
Speaker
Sean Hart, PhD
Chief Scientific Officer & CEO
LumaCyte
Dr. Hart has 50+ peer reviewed journal articles, numerous invited and contributed presentations, 4 patents issued / 4 pending, and has managed large research teams with multi-million dollar budgets. Dr. Hart has extensive experience in a diverse range of research areas including spectroscopy, laser trapping and separation, optical engineering, chromatography, chemical and biochemical separation, statistical data analysis/calibration and artificial intelligence. He received his PhD in Chemistry at Tufts University in 1998. He has significant experience with taking new technology from the lab bench to prototype and field applications.
Register Free: https://www.pharmtech.com/pt_w/label-free
Sponsors
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
